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A transcriptional product of a gene encoding cathepsin B-like peptidase in the bird schistosome
Trichobilharzia regenti was identiﬁed and cloned. The enzyme was named TrCB2 due to its 77% sequence
similarity to cathepsin B2 from the important human parasite Schistosoma mansoni. The zymogen was
expressed in the methylotropic yeast Pichia pastoris; procathepsin B2 underwent self-processing in yeast
media. The peptidolytic activity of the recombinant enzyme was characterised using synthetic ﬂuoro-
genic peptide substrates at optimal pH 6.0. Functional studies using different speciﬁc inhibitors proved
the typical cathepsin B-like nature of the enzyme. The S2 subsite speciﬁcity proﬁle of recombinant TrCB2
was obtained. Using monospeciﬁc antibodies against the recombinant enzyme, the presence of cathepsin
B2 was conﬁrmed in extracts from cercariae (infective stage) and schistosomula (early post-cercarial
stage) of T. regenti onWestern blots. Also, cross-reactivity was observed between T. regenti and S. mansoni
cathepsins B2 in extracts of cercariae, schistosomula or adults. In T. regenti, the antisera localised the
enzyme to post-acetabular penetration glands of cercariae implying an important role in the penetration
of host skin. The ability of recombinant TrCB2 to degrade skin, serum and nervous tissue proteins was
evident. Elastinolytic activity suggests that the enzyme might functionally substitute the histolytic role
of the serine class elastase known from S. mansoni and Schistosoma haematobium but not found in
Schistosoma japonicum or in bird schistosomes.
 2008 Australian Society for Parasitology Inc. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
Trichobilharzia regenti is a nasal avian schistosome related to
important human parasites of the genus Schistosoma. Like those,
bird schistosomatids have complex two-host life cycles. Cercariae
shed into the water environment from an intermediate snail host
must ﬁnd and penetrate the skin of a ﬁnal host. Ultimately, cerca-
riae transform into schistosomula, which in the case of the un-
iquely neurotropic T. regenti migrate through the peripheral
nerves and CNS causing severe pathologies in birds and even in
mammals (Kolárˇová et al., 2001). The parasites mature, mate and
lay eggs only in the nasal cavity of anatid birds (Horák et al.,
1999; Hrádková and Horák, 2002). Occasionally, cercariae of bird
schistosomes can also penetrate into human skin during bathingInc. Published by Elsevier Ltd.
nti cathepsin B2 has been
ccession No. EF682129.
x: +420 224 919 704.
Opand cause an allergic reaction manifested as cercarial dermatitis
(swimmer’s itch) (Horák and Kolárˇová, 2001; Kourˇilová et al.,
2004; Horák et al., 2002), which is considered an emerging disease
in many parts of the world.
Throughout their life cycle, schistosomes employ peptidases for
many indispensable tasks, including host-tissue penetration (Yosh-
ino et al., 1993; Salter et al., 2000, 2002; McKerrow and Salter,
2002), metabolism of host macromolecules for parasite nutrition
(Caffrey et al., 2004; Delcroix et al., 2006) and evasion or manipu-
lation of host immune responses (Marikovsky et al., 1990; Cocude
et al., 1999). Recently, our interest has focused upon cysteine pep-
tidases of parasitic organisms because of their critical importance
to parasite survival, making them valuable targets for rational de-
sign of new efﬁcient anti-parasite drugs (Rosenthal et al., 2002;
Renslo and McKerrow, 2006; Abdulla et al., 2007; Reis et al.,
2007). In medically important Schistosoma mansoni, cathepsin B1,
the predominant cysteine peptidase among several gut-associated
digestive enzymes (Caffrey et al., 2004), is considered an attractive
target for anti-parasite chemotherapy (Abdulla et al., 2007). Inen access under CC BY license.
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and its immunogenicity has been used as one of the main serodiag-
nostic markers for schistosomiasis (Li et al., 1996).
Most studies on human schistosomes have focused on blood-
dwelling developmental stages (schistosomula and adults), but
less is known about cercarial cysteine peptidases. In cercariae of S.
mansoni, cathepsins B and L have been reported to be present in
post-acetabular penetration glands and supposed to be involved in
disruption of the outer keratinised layer of the skin (Dalton et al.,
1996, 1997). Also Kašny´ et al. (2007) demonstrated cysteine pepti-
dase activity of cathepsin B-type in secretions of cercarial penetra-
tion glands. However, Skelly and Shoemaker (2001) localised
cathepsin B1 to the protonephridial system and caeca of S. mansoni
cercariae.
Until recently, a single Clan PA chymotrypsin-like serine pepti-
dase with elastinolytic activity has been considered as the main
penetration tool of schistosome cercariae (Salter et al., 2000,
2002). However, this was found not to be the case for Schistosoma
japonicum (Dvorˇák et al., 2008). Therefore, differences in the
enzymatic equipment used for penetration between different spe-
cies of schistosomes require more detailed examination (Pleass et
al., 2008). Our previous studies showed that no orthologue of
S.mansoni elastase is present in Trichobilharzia and instead cysteine
peptidase activity dominates in the cercariae. Two cysteine pepti-
dases of 31 kDa and 33 kDa have been identiﬁed in the excretory/
secretory (E/S) products of Trichobilharzia szidati and T. regenti
cercariae, respectively (Mikeš et al., 2005). In the latter species,
Kašny´ et al. (2007) showed that the major peptidase activities are
of cysteine peptidase origin – cathepsin B and, to a certain degree,
cathepsin L. The cathepsin B-like activity was present in praziquan-
tel-induced secretions of penetration glands. In a recent study, Do-
lecˇková et al. (2007) retrieved a full-length cDNA sequence coding
for cathepsin B1 from a mixed cDNA library based on intramollus-
can stages (sporocysts and developing cercariae) of T. regenti; this
was 100% homologous to the sequence of the TrCB1.1 isoform ex-
pressed in the gut of schistosomula (Dvorˇák et al., 2005).
In the present study, we have identiﬁed and cloned a cDNA se-
quence encoding a cathepsin B-like peptidase from cercariae of T.
regenti. It was orthologous to S. mansoni and S. japonicum cathepsin
B2 genes (GenBank Accession Nos. AJ312106 and AY226984),
showing almost 80% sequence similarity and is therefore termed
TrCB2. We performed overexpression in Pichia pastoris and charac-
terised the physico-chemical properties and peptide substrate
preferences of the recombinant enzyme. By means of immunohis-
tochemistry, we show the enzyme to be present in cercarial post-
acetabular penetration glands and, ﬁnally, we demonstrate the
ability of TrCB2 to cleave relevant tissue proteins.
2. Materials and methods
2.1. Parasites
Trichobilharzia regenti has been routinely maintained under lab-
oratory conditions (Horák et al., 1998). Infected snails were dis-
sected and the entire digestive gland, containing both snail
tissues and parasitic larval stages (sporocysts with developing
cercariae) excised and used as an initial source of total RNA. Fresh
fully developed cercariae emerging from snails were collected
(Kašny´ et al., 2007), while post-cercarial stages of the parasite
(schistosomula) were obtained from infected ducks 8 days p.i. as
described by Dvorˇák et al. (2005). Live S. mansoni adults were ob-
tained from the Institute for Postgradual Medical Education, Pra-
gue, whereas lyophilised S. mansoni cercariae were from the
School of Biological Sciences, University of Wales, Bangor, UK. Ani-
mal treatment was in concordance with the legislation of the Czech
Republic and the European Union.2.2. Production, cloning and sequencing of TrCB2 cDNA
Using TRIzol (Invitrogen, USA), total RNA was isolated from
homogenate of 10 infected snail hepatopancreases. Subsequently,
mRNA was extracted using a MicroPoly(A)Purist mRNA Puriﬁca-
tion Kit (Ambion, USA). First-strand cDNA synthesis was carried
out with 3 lg of mRNA using oligo-dT18 primer (Generi-Biotech
s.r.o., Czech Republic) and Superscript II Reverse Transcriptase
(Invitrogen, USA) following the manufacturer’s instructions. Ob-
tained cDNA was used as a template for subsequent PCRs.
Two rounds of PCR ampliﬁcations were performed with degen-
erate oligonucleotide primers. The forward primer TrCBdegfrd
1(50-TTYGGNGCNGTNGARGC-30) was the same for both rounds of
PCR, reverse primers TrCBdegrev 2(50-TCNCCCCARTCRCTRTTCCA-
30) and TrCBdegrev 5(50-TTNGCDATYAACCARTANGG-30) were used
in the ﬁrst and second round of PCR, respectively. Ampliﬁed prod-
ucts of the expected size were gel puriﬁed using the MinElute Gel
Extraction Kit (Qiagen), and cloned directly into the pCR2.1-TOPO
cloning vector (Invitrogen). Obtained construct was propagated in
chemically competent Escherichia coli TOP10 cells, isolated using
Qiaprep Puriﬁcation Kit (Qiagen) and sequenced with the M13 for-
ward and M13 reverse primers (DNA Sequencing Laboratory, Fac-
ulty of Science, Charles University in Prague). Full-length cDNA of
cathepsin B was obtained by 50 and 30 rapid ampliﬁcation of cDNA
ends procedures by using the GeneRacerTM Kit (Invitrogen), and its
nucleotide sequence was determined. To examine the presence of
other TrCB2 isoforms, 10 PCR reactions were performed and the
products subcloned into the pCR2.1-TOPO cloning vector for
propagation in E. coli. For each PCR, ﬁve clones were randomly se-
lected for sequencing (50 clones in total).
BLASTp analysis (http://au.expasy.org/tools/blast/) and Clu-
stalW alignment (http://au.expasy.org/tools/#align) of deduced
amino acid sequences were conducted on ExPASy Proteomic Server
of the Swiss Institute of Bioinformatics. The initial position of the
TrCB2 pro-region was predicted with the SignalP software (Nielsen
et al., 1997) at http://www.cbs.dtu.dk/services/SignalP.
2.3. Construction of yeast expression plasmid
The gene was ampliﬁed by PCR from the pCR2.1-TOPO cloning
vector (Invitrogen, USA) using the AccuPrime Pfx DNA polymerase
Kit (Invitrogen). For ampliﬁcation, sense primer KlonTrCB2fwd
50-ATACTCGAGAAAAGAGAGGCTAATCGACACAAGTTTATG-30, con-
taininganXhoI restriction site (underlined)andKex2peptidase cleav-
agesite (inbold), andantisenseprimerKlonTrCB2rev50-ATGCGGCCGC
TTATTTAAGTTTCGGAATTCCAGC-30, containing NotI restriction site
(underlined) and a stop codon (in bold), were used. The 998-bp gene
of procathepsin B2 (proTrCB2) was inserted into the XhoI/NotI dou-
ble-digested expression vector pPICZa B (Invitrogen).
2.4. Expression and puriﬁcation of recombinant TrCB2
The protocol of Dvorˇák et al. (2005) was adopted using wild
type strain X33 of the methylotrophic yeast P. pastoris (Invitrogen)
as a host strain. The cultures of selected transformed clones were
grown for 2 days and centrifuged at 3,000g for 20 min; superna-
tants were clariﬁed by ﬁltration through a 0.22 lm ﬁlter. Complete
buffer exchange with 50 mM sodium acetate pH 5 and approxi-
mately 250-fold concentration was accomplished using AmiconUl-
tra 15 ﬁlters (Millipore; 10,000 MWCO). For puriﬁcation of
recombinant cathepsin B2, a Mono S cation-exchange column
(Amersham Pharmacia) and fast protein liquid chromatography
(FPLC; BioLogic, Bio-Rad) were used. The column was pre-equili-
brated with 50 mM acetate buffer pH 5 at room temperature and
proteins were eluted by use of a linear salt gradient (0–1 M NaCl).
Obtained fractions were analysed by SDS–PAGE. The identity of the
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tides (Proteomics & Analytical Biochemistry, Biology Technology
Facility, University of York, UK).
2.5. N-terminal amino acid sequence analysis
The puriﬁed recombinant TrCB2 was electrophoresed, blotted
onto polyvinylideneﬂuoride (PVDF)membrane, stainedbyCoomas-
sie brilliant blue and submitted for N-terminal Edman sequencing
(Laboratory of Protein Sequencing, Institute of Organic Chemistry
and Biochemistry, Academy of Sciences of the Czech Republic).
2.6. Deglycosylation of puriﬁed recombinant TrCB2
Mixture containing 10 ll of 5 reaction buffer (Native Protein
Deglycosylation Kit; N-DEGLY, Sigma) and 200 lg (37.5 ll) of
TrCB2 was incubated with 2 ll of Endoglycosidase F1 at 37 C for
1 h. Deglycosylated TrCB2 was examined for a shift in molecular
weight by SDS–PAGE analysis.
2.7. TrCB2 peptidase activity, inhibition assays and S2 subsite
speciﬁcity
Typical assay conditions were as follows: TrCB2 (0.5 lg) in
100 ll of 50 mM citrate/100 mM phosphate buffer pH 6.0 (CPB)
containing 5 mM DTT was mixed with 100 ll of 50 lM substrate
in CPB. The pH optimum of TrCB2 activity was determined using
buffers of pH in the range 3.0–8.0 and the cathepsin B-speciﬁc sub-
strate Z-Arg-Arg-AMC. Peptidase activity was measured using ﬂuo-
rogenic aminomethylcoumarin-coupled (AMC) peptide substrates
(Bachem): Z-Phe-Arg-AMC (to assay cathepsins B and L), Z-Arg-
Arg-AMC (cathepsin B), Boc-Val-Leu-Lys-AMC (cathepsins B and
L), Z-Gly-Pro-Arg-AMC (trypsin-like peptidases), Suc-Ala-Ala-Pro-
Phe-AMC (chymotrypsin-like), Boc-Leu-Gly-Arg-AMC (trypsin-
like). Assays were performed in black 96-well plates (Nunc, Den-
mark) using the Inﬁnite M200 ﬂuorometer (TECAN) at excitation
and emission wavelengths of 355 and 460 nm, respectively. The re-
lease of AMC was measured within a period of 60 min.
Inhibition of thepeptidolytic activity of both de- and glycosylated
forms of TrCB2 was tested at pH optimum 6.0 with 100 lM Z-Arg-
Arg-AMC, a substrate speciﬁc for cathepsin B and a spectrum of dif-
ferentiating peptidase inhibitors at 50 lM concentrations: E-64
[N-trans-(epoxysuccinyl)-L-leucine 4-guanidinobutylamide], irre-
versible broad spectrum Clan CA cysteine peptidase inhibitor;
CA-074 [N-(L-3-trans-propylcarbamoyloxirane-2-carbonyl)-Ile-Pro-
OH], irreversible, selective, of cathepsin B (Towatari et al., 1991);
Z-Phe-Ala-CHN2 [Z-Phe-Ala-diazomethylketone], irreversible, of
cathepsins B and L (Dalton et al., 1997); Z-Phe-Phe-CHN2 [Z-Phe-
Phe-diazomethylketone], irreversible, of cathepsins B and L (Nowak
et al., 2004); Z-Phe-Tyr-CHN2, [Z-Phe-Tyr(tBu)-diazomethylketone],
irreversible, of cathepsin L (Shaw et al., 1993); elastatinal [N-(Na-
Carbonyl-Cpd-Gln-Ala-al)-Leu], irreversible, speciﬁc, of neutrophil
andpancreatic elastasesbutnotother serinepeptidases suchas tryp-
sin or chymotrypsin (Bieth, 2004); DFP (diisopropylﬂuoro-phos-
phate), irreversible, of serine peptidases (Bharadwaj et al., 1996).
S2 subsite peptide substrate speciﬁcity of recombinant TrCB2
was examined using a positional scanning synthetic combinatorial
library (PS-SCL) as described by Choe et al. (2006). Enzyme assays
were carried out in CPB pH 6 containing 100 mM NaCl.
2.8. Production of antibodies against TrCB2, blotting and
immunohistochemistry
2.8.1. Antibodies
Antisera against glycosylated (anti-TrCB2) and deglycosylated
(anti-degTrCB2) forms of recombinant TrCB2 were raised in10-week-old BALB/c mice (ANLAB, Germany). The protein dis-
solved in 100 ll of sterile saline was mixed with an equal volume
of TiterMax GoldTM adjuvant (Sigma) and emulsiﬁed by extensive
sonication which also caused inactivation of protease activity.
Two mice for each form of the enzyme were injected s.c. 3 at
10-day intervals (2  35 lg, second booster 25 lg of protein). Im-
mune sera were collected 7 days after the last injection. Control
sera were obtained from mice kept under the same conditions.
For bleeding, mice were anesthetised by ketamine/xylazine. Ani-
mal treatment was in concordance with the legislation of the Czech
Republic and the European Union.
2.8.2. Western blotting
Cercariae and schistosomula of T. regenti and cercariae and
adults of S. mansoni were homogenised by two cycles of sonication
(7 W, 30 s each, Vibracell-72405, Bioblock Scientiﬁc) on ice in
10 mM PBS pH 7.2 and centrifuged at 13,000g, 4 C for 10 min.
The supernatants were used for SDS–PAGE. Cercarial extracts of
T. regenti (200 lg) and S. mansoni (60 lg), schistosomular extract
of T. regenti (100 lg), extract from adult S. mansoni (50 lg) or pure
recombinant TrCB2 (10 lg) were separated by SDS–PAGE in 12%
gels (Prep/2-D sample well comb) using the Mini PROTEAN 3 Sys-
tem (Bio-Rad) and electroblotted onto PVDF membrane. Blocking
was performed by 5% non-fat dry milk in 20 mM Tris–HCl,
150 mM NaCl, pH 7.8, 0.05% Tween 20 (TBS-T) for 1 h. Membranes
were incubated with mouse anti-TrCB2, anti-degTrCB2, rabbit anti-
SmCB2, control mouse and/or rabbit non-immune sera (all 1:50 in
1% BSA/TBS-T) for 1 h, washed, incubated for 1 h with peroxidase-
coupled goat anti-mouse or anti-rabbit IgG diluted 1:1,000 (Sig-
ma), then ﬁnally washed and developed with Opti-4CNTM Substrate
Kit (Bio-Rad).
2.8.3. Ligand blotting
For peptidase-active site labelling, a biotinylated analogue of
the Clan CA cysteine peptidase inhibitor E-64 (DCG-04) (Green-
baum et al., 2000) was used. Brieﬂy, 15 lg of pure recombinant en-
zyme was incubated for 1 h at room temperature with 5 lM DCG-
04 in 50 mM citrate/100 mM sodium phosphate pH 6.0 containing
5 mM DTT. Further, a previously described protocol was adopted
(Mikeš and Man, 2003).
2.8.4. Immunolocalisation of TrCB2
Cercariae of T. regenti were ﬁxed, embedded and sectioned as
described elsewhere (Mikeš et al., 2005). Blocking was performed
in PBS containing 0.05% Tween 20 (PBS-T), 5% non-fat dry milk,
laminarin (1 mg/ml) and a cocktail of peptidase inhibitors (Com-
plete Mini Protease Inhibitor Cocktail tablets – Roche, Germany)
in a wet chamber at 4 C overnight. The slides were then incubated
for 1.5 h with mouse sera (control or anti-TrCB2) diluted 1:50 in 2%
BSA in PBS-T. After extensive washing, sections were incubated for
45 min with AlexaFluor-labelled anti-mouse IgG secondary anti-
bodies (Molecular Probes) diluted 1:500. Sections were mounted
into TBS-buffered glycerol (4:1) and examined using a confocal
microscope equipped with the Acousto-Optical Beam Splitter sys-
tem (Leica).
2.9. Degradation of natural substrates by recombinant TrCB2
The ability of TrCB2 to hydrolyse natural protein substrates was
tested using collagen type IV (from human placenta), elastin (both
insoluble and soluble from bovine neck ligament), ﬁbrinogen type
III (from human placenta, fraction I), keratin (from human epider-
mis), duck, turkey and bovine haemoglobins and myelin basic pro-
tein (from mouse brain).
The substrates (with the exception of elastin) at a ﬁnal concen-
tration of 0.2 mg/ml were incubated with recombinant TrCB2
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Control reactions contained CPB instead of the enzyme. Aliquots
(20 ll) of the resulting hydrolysates were mixed with non-reduc-
ing SDS–PAGE sample buffer, separated by electrophoresis in 15%
SDS–PAGE and subsequently stained with Coomassie brilliant blue.
Degradation of insoluble elastin was tested by two different ap-
proaches. Suspensions containing 5.0 mg of insoluble elastin in
200 ll of CPB pH 6 were supplemented by 5 mM DTT. Reactions
were started by addition of 1 ll (0.8 lg) of the enzyme and shaken
in an Eppendorf Thermomixer Compact at 37 C (1,200 rpm) to
avoid sedimentation. After 2 h incubation, a modiﬁed procedure
of Novinec et al. was applied (2007) , employing ﬂuorescamine
for detection of N-termini of peptidase-generated peptides. Appro-Fig. 1. Multiple alignment of cathepsin B2 from Trichobilharzia regenti (TrCB2; GenBan
GenBank Accession No.AY226984) and Schistosoma mansoni (SmCB2; GenBank Accession
line to the pro-peptide and black line to the predicted mature enzyme. Below the sequ
conservative substitutions are indicated by colons, non-conservative changes are represe
site are shaded in black. Space symbol indicates the possible N-glycosylation site and
experimentally determined by N-terminal Edman degradation of expressed recombina
slightly modiﬁed ‘haemoglobinase motif’, ascribed to those cathepsins B which are ablepriate blanks were run to deduct the ﬂuorescence developed by
elastin and TrCB2 alone. The second experiment employed mass
spectrometry identiﬁcation of TrCB2-generated elastin peptides.
An aliquot was taken from the samples after overnight incubation,
concentrated on C18 ZipTips and applied directly on nano-reverse
phase HPLC-MALDI-TOF-TOF (Laboratory of Mass Spectrometry,
Faculty of Science, Charles University in Prague). Spectra were ac-
quired in positive reﬂectron ion mode; 2,000 subspectra were
integrated.
Moreover, the elastinolytic activity of TrCB2 was conﬁrmed by
digestion of soluble bovine elastin (Sigma E6527). The reaction
was performed in 20 ll of CPB pH 6 containing 4 lg of TrCB2
and 40 lg of soluble elastin. Controls run in parallel eitherk Accession No. EF682129) with cathepsin B2 from Schistosoma japonicum (SjCB;
No.AJ312106). Above the sequences, the dotted line refers to the signal peptide, grey
ences, identities across all three sequences are indicated by asterisks, one or more
nted by points. The conserved His, Cys and Asn residues forming the catalytic active
arrow depicts the cleavage site between the pro-domain and mature peptidase as
nt TrCB2. The ‘occluding loop’ unique to cathepsin B enzymes is underlined. The
to cleave haemoglobin, is indicated in bold face.
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incubation at 37 C was followed by addition of non-reducing
SDS–PAGE sample buffer, the samples were boiled for 3 min. and
electrophoresed in an 8–16% linear gradient precast gel (Bio-Rad).
3. Results
3.1. Sequence analysis of the full-length TrCB2 cDNA clone and
predicted protein
The open reading frame (ORF) of TrCB2 is made up of
1,032 bp and encodes a pre-pro-enzyme of 344 amino acid res-
idues with a calculated mass of 38.5 kDa. The predicted polypep-
tide has signiﬁcant sequence similarity with cathepsins B2 from
human schistosomes (78% to S. japonicum and 77% to S. mansoni)
as shown in Fig. 1. Among the 50 bacterial clones screened, no
sequence coding for another isoform of the enzyme was found.
A potential signal sequence cleavage site was detected between
amino acids at positions 21 and 22, according to SignalP v3.0
software. This would result in a pro-enzyme 323 amino acid res-
idues long with a calculated mol. wt. of 36 kDa and an estimatedFig. 2. Fluorogenic peptide substrate hydrolysis and inhibition studies with de- and gly
compared with a spectrum of aminomethylcoumarine-labelled substrates. (B) Effect of
TrCB2 with the cathepsin B-speciﬁc substrate RR. Composition of substrates is presente
assays ± SD. RFU, relative ﬂuorescent unit.
Fig. 3. Detection of puriﬁed recombinant TrCB2 by SDS–PAGE, ligand and Western blott
Lane 1, DCG-04 binding to the active site of the enzyme; lane 2, binding of DCG-04 inhibi
inactivated enzyme. (B) Shift in the molecular size in SDS–PAGE of yeast-produced TrCB2
endoglycosidase F1 treated enzyme; lane 6, deglycosylation performed in the presence
respectively, on blots of recombinant glycosylated TrCB2. Lanes 7 and 8, controls with b
sera; lane 11, serum against glycosylated TrCB2; lane 12, serum against deglycosylated Tr
sera with the major 32 kDa glycosylated band of yeast-produced TrCB2; reaction also oc
yeast, which is not visible in Coomassie stained gel (lane 4). TrCB2 and SmCB2, cathepspI of 6.5. The predicted mature enzyme has 253 amino acid res-
idues, a calculated mol. wt. 28.5 kDa, pI 5.9 and starts with an
amino acid at position 92. Nevertheless, the results from Edman
degradation showed that the recombinant peptidase was cleaved
into the mature form three amino acids upstream from the pre-
dicted site, between Ser88 and Leu89. Two potential N-glycosyla-
tion sites (Asn-Xaa-Thr/Ser) were identiﬁed at amino acid
positions 46 and 185 of the pre-pro-enzyme. The conserved res-
idues Cys32, His201 and Asn221 forming the typical catalytic triad
of the family C1 of Clan CA cysteine peptidases (Turk et al.,
2000) are present (shaded in black in Fig. 1). Also, the sequence
contains a unique motif (YWLIANSWxxDWGE) ascribed to those
cathepsins B thought to serve as haemoglobinases in blood-feed-
ing helminths (Baig et al., 2002), except that the terminal glu-
tamic acid (E) has been replaced by aspartic acid (D) in TrCB2
sequence. The nucleotide sequence for T. regenti cathepsin B2
has been deposited in the GenBank database (GenBank Accession
No. EF682129). The amino acid sequence of this protein can be
accessed through NCBI Protein Database (NCBI Accession No.
ABS57370). The NC-IUBMB enzyme classiﬁcation of TrCB2 is EC
3.4.22.1.cosylated forms of recombinant TrCB2 at pH optimum 6.0. (A) Peptidolytic activity
cysteine and serine peptidase differentiating inhibitors on peptidolytic activity of
d in single-letter aminoacid code. Values are means of three independent triplicate
ing. (A) Labelling of TrCB2 by the cysteine peptidase-speciﬁc probe DCG-04 on blot.
ted by cysteine peptidase inhibitor E-64; lane 3, weak reaction of DCG-04 with heat-
after deglycosylation with endoglycosidase F1. Lane 4, non-treated enzyme; lane 5,
of E-64. (C) Reaction of mouse and rabbit sera raised against TrCB2 and SmCB2,
uffer instead of primary antibodies; lanes 9 and 10, pre-immune mouse and rabbit
CB2; lane 13, serum against SmCB2. Note the strong reaction of DCG-04 and immune
curs with a minor 30 kDa band of supposedly non-glycosylated TrCB2 produced by
ins B2 of Trichobilharzia regenti and Schistosoma mansoni, respectively.
206 K. Dolecˇková et al. / International Journal for Parasitology 39 (2009) 201–2113.2. Functional expression and puriﬁcation of recombinant TrCB2
TrCB2 was expressed in the methylotropic yeast P. pastoris as a
pro-enzyme, however, it had already undergone self-processing to
a mature active peptidase in yeast medium as conﬁrmed by the re-
sults of N-terminal sequencing (Fig. 1). The activity of the enzyme
was conﬁrmed by ﬂuorometric and inhibition assays (Fig. 2). In
addition, the cysteine peptidase-speciﬁc probe DCG-04 bound spe-
ciﬁcally to a 32/30 kDa doublet on ligand blots (Fig. 3) and mass
spectrometry of the SDS–PAGE-resolved proteins conﬁrmed the
identity of the expression product to be cathepsin B (not shown).
The enzyme was puriﬁed from the medium in a single step by
cation-exchange FPLC. The column fraction containing the greatest
hydrolytic activity against cathepsin B-speciﬁc substrate Z-Arg-
Arg-AMC was subjected to SDS–PAGE. Although the expected
molecular mass of mature TrCB2 was 28.5 kDa, a band migrating
at 32 kDa appeared in the gel. The glycosylation state of the se-
creted recombinant mature enzyme was examined by treatment
with endoglycosidase F1, resulting in a signiﬁcant decrease in
molecular mass to 30 kDa in SDS–PAGE (Fig. 3).
3.3. pH optimum, peptidase assays, inhibition studies and S2 subsite
speciﬁcity
For both glycosylated and deglycosylated forms of TrCB2, the
pH optima for hydrolysis of Z-Arg-Arg-AMC were 6.0. At pH values
below 4.0 and above 6.5 only slight hydrolysis was detected for
both forms of TrCB2 (not shown).Fig. 4. Preference proﬁles of recombinant TrCB2 using a complete diverse positional scan
to corresponding P1–P4 peptide amino acid positions were determined with a library in w
of 20 amino acids. The amino acids are designated by the single-letter code on the x-ax
second.As anticipated, Z-Arg-Arg-AMC, Z-Phe-Arg-AMC and Boc-
Val-Leu-Lys-AMC were degraded, whereas activity with serine
peptidase substrates Boc-Leu-Gly-Arg-AMC and Suc-Ala-Ala-Pro-
Phe-AMC was only negligible. Z-Gly-Pro-Arg-AMC, usually used
for trypsin-like peptidase activity detection, was hydrolysed by
TrCB2 at a similar level as Z-Arg-Arg-AMC dipeptide. No signiﬁcant
differences in activity were observed between de- and glycosylated
TrCB2 with particular substrates (Fig. 2). All cysteine peptidase-
selective inhibitors used had remarkable inhibitory effects on the
activity of TrCB2 with Z-Arg-Arg-AMC substrate. Among serine
peptidase inhibitors, only elastatinal appeared to be potent (Fig. 2).
The positional scanning of the synthetic combinatorial library at
optimal pH employed to probe the S2 speciﬁcities clearly showed
that recombinant TrCB2 displays partial preferences for Lys or
Arg at position P1, Met > Val > Ser > Gln at P2 and Leu and other
hydrophobic amino acids at P3 of peptide substrates. No obvious
preference for an amino acid residue was noted at P4 (Fig. 4).
3.4. Immunoreactivity of TrCB2
Both de- and glycosylated forms of recombinant TrCB2 gave rise
to four mouse polyclonal antisera. Three of those reacted positively
with a protein doublet of 32 and 30 kDa on immunoblots of recom-
binant TrCB2. In addition, cross-reactivity of recombinant TrCB2
with rabbit monospeciﬁc polyclonal antiserum against cathepsin
B2 from S. mansoni (anti-SmCB2) was detected (Fig. 2).
The anti-TrCB2 sera speciﬁcally recognised putative cathepsin
B2 of 34 kDa on Western blots of T. regenti cercariae (Fig. 5A, lanening synthetic combinatorial peptide substrate library. S2 speciﬁcities of the enzyme
hich randomised positions were incorporated by addition of the isokinetic mixture
is (n, norleucine). The y-axis is a 100% scale of picomolar ﬂuorophore produced per
Fig. 5. Reaction of mouse antiserum against TrCB2 and rabbit antiserum against SmCB2 with extracts from various stages of Trichobilharzia regenti and Schistosoma mansoni
life cycles. (A) Cercarial extract of T. regenti, (B) cercarial extract of S. mansoni, (C) schistosomular extract of T. regenti and (D) extract from adult S. mansoni were resolved by
reducing SDS–PAGE, electroblotted to polyvinylidene diﬂuoride membrane and incubated with serum from a mouse immunised with TrCB2 (lanes 1), a rabbit immunised
with SmCB2 (lanes 2), a non-immunised mouse (lanes 3) and from a non-immunised rabbit (lanes 4). Arrowheads show presumptive cathepsin B2 bands.
Fig. 6. Immunolocalisation of cathepsin B2 in longitudinal and transverse sections of cercariae of Trichobilharzia regenti by indirect immuno-ﬂuorescence microscopy. (A)
Sections incubated with mouse anti-TrCB2 and then with AlexaFluor-labelled anti-mouse IgG. Positive reaction is apparent in post-acetabular penetration glands and their
ducts. (B) Section of T. regenti cercariae was stained with H & E solution. Post-acetabular glands and their ducts appear in black. Arrowheads point to the circumacetabular
glands. (C) Control with pre-immune mouse serum; no reaction is visible.
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lane 1). Anti-TrCB2 also reacted with an 31 kDa protein from
cercariae and an 31 kDa band from adults of S. mansoni (Fig. 5B
and D, lanes 1). Reciprocally, rabbit anti-SmCB2 speciﬁcally recog-
nised particular proteins in extracts of both parasite species (Fig.
5A–D, lanes 2).
By means of immuno-ﬂuorescence confocal microscopy with
speciﬁc anti-TrCB2 serum, the enzyme was localised in post-ace-
tabular penetration glands of T. regenti cercariae (Fig. 6). No signal
was observed in other parts of cercarial bodies.
3.5. Processing of macromolecular natural substrates by recombinant
TrCB2
Most of the selected natural protein substrates used in the
study (skin proteins keratin, collagen and elastin, neural myelin
basic protein, serum ﬁbrinogen) were efﬁciently degraded by re-
combinant TrCB2 at pH 6.0. Haemoglobinolytic activity of the en-
zyme tested with turkey, bovine and duck haemoglobins was
negligible (Figs. 7 and 8).
4. Discussion
Following our previous biochemical studies, here we employed
a molecular approach to gain a more extensive insight into the pro-
teolytic equipment of bird schistosome cercariae. A novel cathep-
sin B peptidase from the nasal neurotropic ﬂuke T. regenti was
identiﬁed, functionally expressed and characterised; according toits high sequence similarity to cathepsins B2 of human schisto-
somes, the enzyme was termed TrCB2. Sequencing of the ORF of
TrCB2 revealed that all of the characteristic features of the C1 fam-
ily of Clan A cysteine peptidases were present, most notably the
catalytic triad (Cys32, His201 and Asn221) and an occluding loop
(residues Pro104–Cys130), the latter presumably providing the
enzyme with peptidyl-dipeptidase (exopeptidase) activity (Musil
et al., 1991). The recombinant T. regenti cathepsin B2 was obtained
in an active mature form, implying self-activation by slitting-off
the pro-domain under the conditions of yeast media and obviating
the need for protein refolding and/or activation steps. Accordingly,
the straightforward expression and puriﬁcation of mature cathep-
sin B2 from S. mansoni, which is the most related peptidase to
TrCB2 regarding sequence similarity, was reported (Caffrey et al.,
2002).
The expected size of mature TrCB2 was 28.5 kDa. However, re-
combinant TrCB2 isolated from P. pastoris culture media was deter-
mined to have a greater molecular size of 32 kDa by SDS–PAGE.
The difference between predicted mass and the mass of migrating
expression product could be explained partially by the cleavage of
the pro-enzyme three amino acids upstream of the predicted site.
Alternatively, the difference could be the result of yeast-produced
Asn-linked N-glycosylation (Bretthauer and Castellino, 1999). In-
deed, after incubation of the 32 kDa TrCB2 with endoglycosidase
F1 cleaving oligomannoside and hybrid oligosaccharides, the
molecular mass of the deglycosylated protein signiﬁcantly de-
creased from 32 to 30 kDa. More sensitive ligand and Western
blotting analyses showed a double band of 32 and 30 kDa prior
Fig. 7. Digestion of selected natural substrates by recombinant cathepsin B2 from
Trichobilharzia regenti (TrCB2). The substrates at a ﬁnal concentration of 0.2 mg/ml
were incubated in the presence (+) or absence () of recombinant TrCB2 (1 lg) in
50 ll of citrate–phosphate buffer pH 6 containing 2 mM DTT at 37 C overnight.
Control reactions () contained CPB instead of the enzyme. Aliquots (20 ll) of the
resulting hydrolysates were separated by electrophoresis and stained with
Coomassie brilliant blue. Substrates used: Gel (A) haemoglobin, lanes 1, from duck;
lanes 2, bovine; lanes 3, turkey; Gel (B) lanes 4, collagen type IV; lanes 5, keratin;
lanes 6, ﬁbrinogen type III; lanes 7, myelin basic protein. Arrowheads indicate
bands corresponding to recombinant TrCB2. Note that all substrates were efﬁciently
degraded, except for haemoglobins hydrolysed only at a negligible rate.
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minority of TrCB2 molecules produced by yeast can be non-glycos-
ylated. Although hyperglycosylation by yeast may have resulted in
an inactive recombinant protein, both de- and glycosylated forms
of TrCB2 were enzymatically active, not differing signiﬁcantly in
their speciﬁc activities and optimum pH 6.
Besides cathepsin B-speciﬁc substrate Z-Arg-Arg-AMC, TrCB2
was able to hydrolyse other cysteine peptidase-speciﬁc substrates:
Z-Phe-Arg-AMC and Boc-Val-Leu-Lys-AMC. Z-Gly-Pro-Arg-AMC,commonly used for serine peptidase detection, was also sensitive
to hydrolysis; this could be explained by the presence of highly
preferred Arg at P1 position of the substrate. The preferences of
TrCB2 for particular amino acids in positions P1 through P4 (P1: Ly-
s > Arg; P2: Met > Val > Ser > Gln; P3: Leu and other hydrophobic
aminoacids; P4: X) conform to those mapped for S. mansoni cathep-
sin B2 using similar libraries (Choe et al., 2006). Cathepsin B-like
peptidases of parasites were conﬁrmed by the complete diverse
PS-SCL assays to have broad and overall substrate speciﬁcity simi-
lar to other cysteine cathepsins. A high substrate promiscuity of
cathepsins B has been suggested (Spiess et al., 1994; Khersonsky
et al., 2006).
The peptidolytic activity of TrCB2 was efﬁciently inhibited by
the general Clan CA cysteine peptidase inhibitor E-64, as well as
by inhibitors speciﬁc for cathepsins B and L (Z-Phe-Ala-CHN2 and
Z-Phe-Phe-CHN2) and cathepsin B (CA-074). Z-Phe-Tyr-CHN2 also
fully inhibited TrCB2 at the given concentration, although it is of-
ten mentioned as being speciﬁc for cathepsins L rather than
cathepsins B (Klose et al., 2006). Strikingly, elastatinal, a speciﬁc
inhibitor of neutrophil and pancreatic elastases (serine class pepti-
dases), showed a level of inhibition comparable to inhibitors spe-
ciﬁc for cysteine peptidases. This phenomenon was reported by
Kašny´ et al. (2007), who suggested that, considering the structure
of elastatinal [N-(Na-Carbonyl-Cpd-Gln-Ala-al)-Leu] and the struc-
ture of the cysteine peptidase inhibitor Z-Phe-Ala-CHN2 (which
was also a good inhibitor of TrCB2 activity in this study), the alde-
hyde located on Ala2 situated in P1 position of elastatinal is proba-
bly able to inhibit cysteine peptidase activity. The activity and
inhibition data presented here corroborate previously reported re-
sults on cathepsins B of schistosome ﬂukes (Caffrey et al., 2002;
Dvorˇák et al., 2005).
The immunocross-reactivity of proteins among closely related
schistosome species is quite common, due to the similarity of
shared epitopes recognised by the host immune system. Conse-
quently, the detected cross-reactivity of anti-SmCB2 with recombi-
nant TrCB2 was not surprising because the amino acid sequence
similarity of TrCB2 and SmCB2 was as high as 77%. The conspicu-
ous differences between molecular sizes of the cross-reacting pro-
teins recognised by the anti-TrCB2 and anti-SmCB2 sera in the
extracts from different life stages of T. regenti and S. mansoni could
be explained by the various kinds or extent of post-translational
modiﬁcations, most probably glycosylation. Although cathepsin
B2 has been reported only from adults and schistosomula of S.
mansoni, in our study, the presence of SmCB2 was identiﬁed for
the ﬁrst time, to our knowledge, in S. mansoni cercariae via the
reaction of an 31 kDa band on Western blot of cercarial extracts
with sera raised against both SmCB2 or TrCB2. In S. mansoni,
cathepsin B2 is found in tegumental tubercles and parenchyma
of adult males and to a lesser extent in female worms. Therefore,
it has been suggested to be likely lysosomal and act at the para-
site–host interface by participating in the turnover of tegumental
proteins, the degradation of endocytosed proteins and/or operating
in a protective capacity (Caffrey et al., 2002). However, no studies
have been performed on the capability of SmCB2 to cleave relevant
protein substrates. In the case of T. regenti, immunohistochemistry
of cercariae using anti-TrCB2 antibodies localised the enzyme to
the post-acetabular penetration glands. These are specialised cells,
whose secretions help penetrating larvae to disrupt host surface
epithelia and underlying tissues of the skin. Our ﬁnding outlines
a probable role of this enzyme in aiding cercarial penetration of
their hosts.
In vitro studies showed that recombinant TrCB2 is capable of
digesting skin/nervous tissue macromolecules (collagen, elastin,
keratin and myelin basic protein), supporting the above-men-
tioned putative role of TrCB2 in host skin invasion and subsequent
migration through nervous tissues. Although it has been widely
Fig. 8. Digestion of elastin by recombinant cathepsin B2 from Trichobilharzia regenti (TrCB2). Insoluble (A and B) or soluble (C) elastin in citrate-phosphate buffer pH 6 was
incubated with recombinant TrCB2. (A) The reaction was stopped by adition of trichloracetic acid, centrifuged and an aliquot combined with a 0.2 M sodium borate buffer, pH
8.5 and ﬂuorescamine solution. The ﬂuorescence of labelled peptides was measured at kex = 390 nm and kem = 480 nm. Graph shows the difference in ﬂuorescence of sample
containing both substrate and enzyme compared with controls with either the enzyme or substrate alone, indicating the presence of new peptides originating from elastin
digested by TrCB2. Values are means of triplicate assays ± SD. E, elastin; RFU, relative ﬂuorescence unit. (B) The samples were concentrated and applied directly on nano-
reverse phase-HPLC-MALDI-TOF-TOF. Bolded amino acids show partial sequences deciphered by mass spectrometry analysis as unique for sample containing both elastin and
TrCB2. (C) SDS–PAGE proof of soluble elastin degradation by the 32 kDa TrCB2 (lane 1); no hydrolysis was observed in the presence of E-64 inhibitor of cysteine peptidases
(lane 2); soluble elastin band (lane 3) is indicated by an arrowhead.
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by serine peptidases of elastase-like type localised in circumace-
tabular penetration glands (Salter et al., 2000, 2002), the participa-
tion of cathepsin B-like cysteine peptidases in this process has
been previously hypothesised (Dalton et al., 1997) and is sup-
ported by our studies. The potency of cathepsins B to cleave elastin
has been previously conﬁrmed with human cathepsin B, although
cathepsin L had a higher activity on this substrate (Mason et al.,
1986). Here we believe we report the ﬁrst demonstration of elas-
tinolytic activity by a parasite cathepsin B.
In our experiment with insoluble elastin, DTT was used to pro-
tect the nucleophilic thiol group of cysteines in the cysteine pepti-
dase-active site. We are aware that it has also a denaturating effect
on some proteins. It serves as a reducing agent, disrupting disul-
phide bonds within polypeptide molecules or between protein
subunits, thus breaking up tertiary or quaternary structures. How-
ever, in the case of elastin, disulphide bridges do not occur be-
tween particular tropoelastin molecules forming the elastin
polymer. These are cross-linked via desmosine/isodesmosine
bonds derived from speciﬁc lysines. Only one intramolecular disul-
phide bridge is present within the tropoelastin subunit; this inter-
connects the only two cysteines of the mature tropoelastin which
are located near the C-terminus. The intrachain disulphide bond
in the carboxy terminal domain of tropoelastin stabilises a loop
structure and positively charged pocket (Brown et al., 1992). We
think that the change in the tertiary structure of the C-terminus
could hardly affect the accessibility of the rest of the elastin mole-
cule for proteolytic cleavage by TrCB2 which occurred in glycine-,
valine- and proline-rich areas of b-spirals of the elastin molecule
(Rucker and Dubick, 1984) as detected by mass spectrometry of
newly arisen peptides. Furthermore, the reducing power of DTT
is limited to pH values above 7, since only the negatively charged
thiolate form –S is reactive (the protonated thiol form –SH is not);
the pKa of thiol groups is typically 8.3 (Cleland, 1964). Our exper-
iment was performed at pH 6. Finally, the cleavage of ‘‘soluble elas-tin” was performed in DTT-free buffer. Therefore, we believe that
we can afﬁrm that TrCB2 possesses true elastinolytic activity. The
question remains, what is the rate of T. regenti cathepsin B2-spe-
ciﬁc activity in comparison to the elastase of S. mansoni.
In the case of cercariae of T. regenti, cercarial secretions display
a high cathepsin B-like activity and moreover, the presence of an
elastase orthologue was not conﬁrmed using biochemical (Kašny´
et al., 2007), immunological (Mikeš et al., 2005) or molecular ap-
proaches (Dolecˇková et al., 2007). Thus, the competence of TrCB2
to cleave elastin (one of the major components of vertebrate skin)
indicates that this enzyme could functionally substitute for the role
of the chymotrypsin-like serine peptidase referred to foremost as
‘‘cercarial elastase” in S. mansoni.
The evidence presented above leads us to suggest that during
skin invasion, cercariae of T. regenti use enzymatic tools which
are distinct from those of S. mansoni. These rather resemble the sit-
uation in cercariae of S. japonicum, where no elastase-like serine
peptidases have been identiﬁed and where, on the contrary, a high
level of cathepsin B activity is detected. It has been proposed by
these authors that cysteine peptidases represent an archetypal tool
for tissue invasion among primitive metazoa and the use of serine
peptidases arose later in schistosome evolution (Dvorˇák et al.,
2008).
In order to determine possible substrates for peptidase activity
released during schistosomula migration through nervous tissues,
we observed that myelin basic protein is a far better substrate
for hydrolysis by recombinant TrCB2 than haemoglobin. Although
TrCB2 contains a sequence motif similar to that contained in
cathepsin B involved in the digestion of haemoglobin by blood-
feeding helminths (Baig et al., 2002), this motif is slightly changed
by the substitution in the last amino acid, as in the case of SmCB2
and SjCB2 (see Fig. 1). These results imply that TrCB2 is not in-
volved in in vivo degradation of haemoglobin but is employed
against nervous system material (e.g. myelin basic protein) in or-
der to facilitate parasite migration through the nerves.
210 K. Dolecˇková et al. / International Journal for Parasitology 39 (2009) 201–211To elucidate the roles of cathepsin B-like cysteine peptidases
throughout life cycles of different schistosome species, their
expression in particular parasite stages and tissues should be
proved and detailed functional experiments need to be conducted.
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